Biotech Growth Trust (The) (LSE:BIOG) Debt-to-Equity : 0.04 (As of Sep. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Biotech Growth Trust (The) Debt-to-Equity?

Biotech Growth Trust (The)'s Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was £0.00 Mil. Biotech Growth Trust (The)'s Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was £11.44 Mil. Biotech Growth Trust (The)'s Total Stockholders Equity for the quarter that ended in Sep. 2023 was £293.42 Mil. Biotech Growth Trust (The)'s debt to equity for the quarter that ended in Sep. 2023 was 0.04.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Biotech Growth Trust (The)'s Debt-to-Equity or its related term are showing as below:

LSE:BIOG' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.07 Max: 0.17
Current: 0.04

During the past 13 years, the highest Debt-to-Equity Ratio of Biotech Growth Trust (The) was 0.17. The lowest was 0.03. And the median was 0.07.

LSE:BIOG's Debt-to-Equity is ranked better than
86.43% of 1017 companies
in the Asset Management industry
Industry Median: 0.19 vs LSE:BIOG: 0.04

Biotech Growth Trust (The) Debt-to-Equity Historical Data

The historical data trend for Biotech Growth Trust (The)'s Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Growth Trust (The) Debt-to-Equity Chart

Biotech Growth Trust (The) Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

Get a 7-Day Free Trial

0.03

0.09

0.05

0.08

0.06

Biotech Growth Trust (The) Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial															0.04	0.08	0.06	0.06	0.04

Competitive Comparison of Biotech Growth Trust (The)'s Debt-to-Equity

For the Asset Management subindustry, Biotech Growth Trust (The)'s Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotech Growth Trust (The)'s Debt-to-Equity Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Biotech Growth Trust (The)'s Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Biotech Growth Trust (The)'s Debt-to-Equity falls into.

Biotech Growth Trust (The) Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Biotech Growth Trust (The)'s Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	20.17)	/	330.291
	=	0.06

Biotech Growth Trust (The)'s Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	11.437)	/	293.417
	=	0.04

Biotech Growth Trust (The) (LSE:BIOG) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Biotech Growth Trust (The) Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Biotech Growth Trust (The)'s Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotech Growth Trust (The) (LSE:BIOG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

BIOGl:UK

Address

25 Southampton Buildings, London, GBR, WC2A 1AL

Website

https://www.biotechgt.com

Biotech Growth Trust (The) PLC is a United Kingdom-based investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world. The company portfolio comprises emerging biotechnology companies across North America, Europe, and Asia, of which North America accounts for the investment share.

Biotech Growth Trust (The) (LSE:BIOG) Headlines

No Headlines